ENSTILAR® CUTANEOUS FOAM 50mcg/g + 0.5mg/g
Product details
Registration number: SIN15892P
Classification: Prescription Only
Active ingredients:
- Betamethasone dipropionate eqv. Betamethasone
- Calcipotriol monohydrate eqv. Calcipotriol
Strength:
- 0.5mg/g
- 52.2mcg/g
Dosage form: AEROSOL, FOAM
Route: TOPICAL; CUTANEOUS
Registrant: DKSH SINGAPORE PTE. LTD.
ATC code: D05AX52
HSA approval date: 27 February 2020
Manufacturer(s): LEO Laboratories Ltd
Manufacturing country/countries: IRELAND
What are the HSA registration number and classification for ENSTILAR® CUTANEOUS FOAM 50mcg/g + 0.5mg/g?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15892P
Classification: Prescription Only
What active ingredients and strength are recorded for ENSTILAR® CUTANEOUS FOAM 50mcg/g + 0.5mg/g?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Betamethasone dipropionate eqv. Betamethasone
- Calcipotriol monohydrate eqv. Calcipotriol
Strength:
- 0.5mg/g
- 52.2mcg/g
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ENSTILAR® CUTANEOUS FOAM 50mcg/g + 0.5mg/g?
According to the HSA dataset updated 7 August 2026:
Dosage form: AEROSOL, FOAM
Route: TOPICAL; CUTANEOUS
Who is the recorded registrant for ENSTILAR® CUTANEOUS FOAM 50mcg/g + 0.5mg/g?
According to the HSA dataset updated 7 August 2026:
Registrant: DKSH SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for ENSTILAR® CUTANEOUS FOAM 50mcg/g + 0.5mg/g?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): LEO Laboratories Ltd
Manufacturing country/countries: IRELAND
Where can I look up ENSTILAR® CUTANEOUS FOAM 50mcg/g + 0.5mg/g in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15892P or the exact product name ENSTILAR® CUTANEOUS FOAM 50mcg/g + 0.5mg/g. The general register link does not preselect this product.
What are the source dates for this ENSTILAR® CUTANEOUS FOAM 50mcg/g + 0.5mg/g record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ENSTILAR® CUTANEOUS FOAM 50mcg/g + 0.5mg/g record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15892P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)